Multi-scale pharmaceutical process understanding: From particle to powder to dosage form

Chemical Engineering Science

Volumn 65, Issue 21, 2010, Pages 5625-5638

  Hamad, Mazen L ^a   Bowman, Keith ^b   Smith, Nathan ^c   Sheng, Xiaohong ^d   Morris, Kenneth R ^a  

^a UNIVERSITY OF HAWAII AT HILO   (United States)

^b PURDUE UNIVERSITY   (United States)

^c Harris Corporation Gscd ^*  (United States)

^d PURDUE UNIVERSITY   (United States)

Author keywords

Informatics; Materials processing; Particle; Pharmaceuticals; Powders; Systems engineering

Indexed keywords

ACTIVE PHARMACEUTICAL INGREDIENTS; ANISOTROPIC PROPERTY; BULK POWDERS; CRITICAL ISSUES; CRYSTALLINITIES; DEGREE OF CRYSTALLINITY; DIFFERENT SCALE; DISSOLUTION RATES; DOSAGE FORMS; ENGINEERED MATERIALS; INFORMATICS; INFORMATICS DATABASE; KEY ELEMENTS; MATERIALS PROCESSING; MULTISCALES; PARTICLE; PHARMACEUTICAL MATERIALS; PHARMACEUTICAL PROCESS; PHARMACEUTICAL PRODUCTS; PHARMACEUTICALS; POWDER FLOW; PROCESS UNDERSTANDING;

DISSOLUTION; DRUG PRODUCTS; INFORMATION SCIENCE; MECHANICAL PROPERTIES; SOLUBILITY; SYSTEMS ENGINEERING; TENSILE STRENGTH;

POWDERS;

EID: 77957365788     PISSN: 00092509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ces.2010.01.037     Document Type: Article

References (34)

1. Byrn S.R., Sutton P.A., Tobias B., Frye J., Main P. Crystal structure, solid-state NMR spectra, and oxygen reactivity of five crystal forms of prednisolone tert-butylacetate. Journal of the American Chemical Society 1988, 110:1609-1614.
2. Carr R.L. Powder and granule properties and mechanics. Chemical Processing and Engineering 1976, 8:13-88.
3. Carstensen J.T., Dali M. Determination of mass transfer dissolution rate constants from critical time of dissolution of a powder sample. Pharmaceutical Development and Technology 1999, 4:1-8.
4. Duncan-Hewitt W.C., Weatherly G.C. Modeling the uniaxial compaction of pharmaceutical powders using the mechanical properties of single crystals. II: Brittle materials. Journal of Pharmaceutical Sciences 1990, 79:273-278.
5. Duncan-Hewitt W.C., Weatherly G.C. Modeling the uniaxial compaction of pharmaceutical powders using the mechanical properties of single crystals. I: Ductile materials. Journal of Pharmaceutical Sciences 1990, 79:147-152.
6. FDA, 2004. Guidance for industry: PAT-a framework for innovative pharmaceutical development, manufacturing, and quality assurance.
7. Engers D.A., Fricke M.N., Newman A.W., Morris K.R. Triboelectric charging and dielectric properties of pharmaceutically relevant mixtures. Journal of Electrostatics 2007, 65:571-581.
8. Engers D.A., Fricke M.N., Storey R.P., Newman A.W., Morris K.R. Triboelectrification of pharmaceutically relevant powders during low-shear tumble blending. Journal of Electrostatics 2006, 64:826-835.
9. Gupta A., Peck G.E., Miller R.W., Morris K.R. Influence of ambient moisture on the compaction behavior of microcrystalline cellulose powder undergoing uni-axial compression and roller-compaction: a comparative study using near-infrared spectroscopy. Journal of Pharmaceutical Sciences 2005, 94:2301-2313.
10. Hancock B.C., Shamblin S.L., Zografi G. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharmaceutical Research 1995, 12:799-806.
11. Hancock B.C., Zografi G. The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids. Pharmaceutical Research 1994, 11:471-477.
12. Heckel R.W. Density-pressure relations in powder compaction. Transactions of the American Institute of Mining, Metallurgical and Petroleum Engineers 1961, 221:671-675.
13. Hiestand H.E.N., Smith D.P. Indexes of tableting performance. Powder Technology 1984, 38:145-159.
14. Hubbard W.K. Prescription drug products; levothyroxine sodium. Federal Register 1997, 62:43535-43538.
15. Iveson S.M., Litster J.D., Hapgood K., Ennis B.J. Nucleation, growth and breakage phenomena in agitated wet granulation processes: a review. Powder Technology 2001, 117:3-39.
16. Johnson R.A., Wichern D.W. Applied Multivariate Statistical Analysis 2007, Pearson, Upper Saddle River, NJ.
17. Kannamkumarath S.S., Wuilloud R.G., Stalcup A., Caruso J.A., Patel H., Sakr A. Determination of levothyroxine and its degradation products in pharmaceutical tablets by HPLC-UV-ICP-MS. Journal of Analytical Atomic Spectrometry 2004, 19:107-113.
18. Kuppuswamy R., Anderson S.R., Hoag S.W., Augsburger L.L. Practical limitations of tableting indices. Pharmaceutical Development and Technology 2001, 6:505-520.
19. Morris K., Rodriguez N. Hydrates. Encyclopedia of Pharmaceutical Technology 1993, 393-440. Marcel Dekker Inc., New York. K. Morris, N. Rodriguez (Eds.).
20. Patel H., Stalcup A., Dansereau R., Sakr A. The effect of excipients on the stability of levothyroxine sodium pentahydrate tablets. International Journal of Pharmaceutics 2003, 264:35-43.
21. Pinal R. Effect of molecular symmetry on melting temperature and solubility. Organic and Biomolecular Chemistry 2004, 2:2692-2699.
22. Pitkin C., Carstensen J.T. Effect of particle shape on some bulk solids properties. Drug Development and Industrial Pharmacy 1990, 16:1-12.
23. Sheng, X., 2009. Drug dissolution from pregelatinized corn starch capsules. Ph.D. Dissertation, Purdue University, West Lafayette, IN.
24. Singh R.K., Singh B.P., Asthana B.P., Pathak C.M. Deconvolution of lorentzian Raman linewidth: techniques of polynomial fitting and extrapolation. Journal of Raman Spectroscopy 1994, 25:423-428.
25. Smith, N.J., 2007. Mechanistic evaluation of milling and lubrication effects during dry granulation on tableting and mechanical properties of microcrystalline cellulose. Ph.D. Dissertation, Purdue University, West Lafayette, IN.
26. Sun C., Grant D.J.W. Influence of crystal shape on the tableting performance of l-lysine monohydrochloride dihydrate. Journal of Pharmaceutical Sciences 2001, 90:569-579.
27. Swaminathan V., Kildsig D.O. Polydisperse powder mixtures: effect of particle size and shape on mixture stability. Drug Development and Industrial Pharmacy 2002, 28:41-48.
28. Swaminathan V., Kildsig D.O. The effect of particle morphology on the physical stability of pharmaceutical powder mixtures: the effect of surface roughness of the carrier on the stability of ordered mixtures. Drug Development and Industrial Pharmacy 2000, 26:365-373.
29. Te R.L., Griesser U.J., Morris K.R., Byrn S.R., Stowell J.G. X-ray diffraction and solid-state NMR investigation of the single-crystal to single-crystal dehydration of thiamine hydrochloride monohydrate. Crystal Growth and Design 2003, 3:997-1004.
30. Tromans D., Meech J.A. Enhanced dissolution of minerals: stored energy, amorphism and mechanical activation. Minerals Engineering 2001, 14:1359-1377.
31. Venkatasubramanian V., Morris K.R. Drinking from a fire hose. Pharmaceutical Technology Europe 2008, 20:40-46.
32. Venkatasubramanian V., Zhao C., Joglekar G., Jain A., Hailemariam L., Suresh P., Akkisetty P., Morris K., Reklaitis G.V. Ontological informatics infrastructure for pharmaceutical product development and manufacturing. Computers and Chemical Engineering 2006, 30:1482-1496.
33. Wildfong P.L.D., Hancock B.C., Moore M.D., Morris K.R. Towards an understanding of the structurally based potential for mechanically activated disordering of small molecule organic crystals. Journal of Pharmaceutical Sciences 2006, 95:2645-2656.
34. Zhao Z., Ramesh M., Raabe D., Cuitino A.M., Radovitzky R. Investigation of three-dimensional aspects of grain-scale plastic surface deformation of an aluminum oligocrystal. International Journal of Plasticity 2008, 24:2278-2297.